Vallon Pharmaceuticals Inc. (VLON)’s Rally on Review of Strategic Alternatives Culminates in Corrections
On Friday, April 22, 2022, shares of the developer of the abuse-deterrent drugs, Vallon Pharmaceuticals Inc. (VLON) saw a huge uptick as investors flocked to